共 38 条
- [31] Urowitz M.B., Bookman A.A., Koehler B.E., Et al., The bimodal mortality pattern of systemic lupus erythematosus, Am J Med, 60, pp. 221-225, (1976)
- [32] Hermansen M.-L., Lindhardsen J., Torp-Pedersen C., Et al., Incidence of Systemic Lupus Erythematosus and Lupus Nephritis in Denmark: A Nationwide Cohort Study, J Rheumatol, 43, pp. 1335-1339, (2016)
- [33] Moss K.E., Ioannou Y., Sultan S.M., Et al., Outcome of a cohort of 300 patients with systemic lupus erythematosus attending a dedicated clinic for over two decades, Ann Rheum Dis, 61, pp. 409-413, (2002)
- [34] Sun Y., Zhou C., Zhao J., Et al., Systemic lupus erythematosus–associated diffuse alveolar hemorrhage: a single-center, matched case–control study in China, Lupus (Los Angel), 29, pp. 795-803, (2020)
- [35] Prabu A., Patel K., Yee C.-S., Et al., Prevalence and risk factors for pulmonary arterial hypertension in patients with lupus, Rheumatology (Oxford), 48, pp. 1506-1511, (2009)
- [36] Kazzaz N.M., Coit P., Lewis E.E., Et al., Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival, Lupus Sci Med, 2, (2015)
- [37] Min H.K., Lee J.H., Jung S.M., Et al., Pulmonary hypertension in systemic lupus erythematosus: an independent predictor of patient survival, Korean J Intern Med, 30, pp. 232-241, (2015)
- [38] Kandane-Rathnayake R., Golder V., Louthrenoo W., Et al., Lupus low disease activity state and remission and risk of mortality in patients with systemic lupus erythematosus: a prospective, multinational, longitudinal cohort study, Lancet Rheumatol, 4, pp. e822-e830, (2022)